HIV postexposure prophylaxis use among ontario female adolescent sexual assault victims: A prospective analysis

Sexually Transmitted Diseases

Volumn 35, Issue 12, 2008, Pages 973-978

  Du Mont, Janice ^a,b   Myhr, Terri L ^a   Husson, Heather ^c   MacDonald, Sheila ^b,d   Rachlis, Anita ^e,f   Loutfy, Mona R ^a,f  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d Ontario Network of Sexual Assault/Domestic Violence Treatment Centres   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; CANADA; CHILD; DIARRHEA; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HIGH RISK PATIENT; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MARRIAGE; NAUSEA; PATIENT COMPLIANCE; PROPHYLAXIS; PROSPECTIVE STUDY; SCHOOL CHILD; SEXUAL ABUSE; SEXUAL CRIME; STUDENT; TREATMENT DURATION; VICTIM; VOMITING; CHILD BEHAVIOR; COUNSELING; DISEASE TRANSMISSION; HEALTH CARE QUALITY; PSYCHOLOGICAL ASPECT; STATISTICS;

ADOLESCENT; ADOLESCENT BEHAVIOR; ANTI-HIV AGENTS; CHILD; COUNSELING; CRIME VICTIMS; FEMALE; HIV INFECTIONS; HUMANS; ONTARIO; PATIENT COMPLIANCE; PROGRAM EVALUATION; SEX OFFENSES; YOUNG ADULT;

EID: 58849116399     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181824f3c     Document Type: Article

References (39)

1. Kaplan DW, Feinstein RA, Fisher MM, et al. Care of the adolescent sexual assault victim. Pediatrics 2001; 107:1476-1479.
2. Irwin CE Jr, Rickert VI. Coercive sexual experiences during adolescence and young adulthood: a public health problem. J Adolesc Health 2005; 36:359-361.
3. Jewkes R, Sen P, Garcia-Moreno C. Sexual violence. In: Krug EG, Dahlberg LL, Mercy JA, et al, eds. World Report on Violence and Health. Geneva: World Health Organization, 2002:148-181.
4. Decker MR, Raj A, Silverman JG. Sexual violence against adolescent girls: influences of immigration and acculturation. Violence Against Women 2007; 13:498-513.
5. Howard DE, Wang MQ. Psychosocial correlates of US adolescents who report a history of forced sexual intercourse. J Adolesc Health 2005; 36:372-379.
6. Silverman JG, Raj A, Mucci LA, et al. Dating violence against adolescent girls and associated substance use, unhealthy weight control, sexual risk behavior, pregnancy, and suicidality. JAMA 2001; 286:572-579.
7. Upchurch DM, Kusunoki Y. Associations between forced sex, sexual and protective practices, and sexually transmitted diseases among a national sample of adolescent girls. Womens Health Issues 2004; 14:75-84.
8. amfAR AIDS Research. Gender-based violence and HIV among women: assessing the evidence. Available at: http://www.amfar.org/binary-data/ AMFAR-PUBLICATION/download-file/38.pdf. Accessed October 4, 2007.
9. Holmes MM, Resnick HS, Kilpatrick DG, et al. Rape-related pregnancy: estimates and descriptive characteristics from a national sample of women. Am J Obstet Gynecol 1996; 175:320-324.
10. Jones JS, Rossman L, Wynn BN, et al. Comparative analysis of adult
11. versus adolescent sexual assault: epidemiology and patterns of anogenital injury. Acad Emerg Med 2003; 10:872-877.
12. White C, McLean I. Adolescent complainants of sexual assault; injury patterns in virgin and non-virgin groups. J Clin Forensic Med 2006; 13:172-180.
13. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006; 55(RR-11):1-94.
14. Olshen E, Samples CL. Postexposure prophylaxis: an intervention to prevent human immunodeficiency virus infection in adolescents. Curr Opin Pediatr 2003; 15:379-384.
15. Centers for Disease Control and Prevention. Antiretroviral postexpo-sure prophylaxis after sexual, injection drug use, or other nonoccu- pational exposure to HIV in the United States: recommendations from the US Department of Health and Human Services. MMWR Recomm Rep. 2005; 54(RR-2):1-19.
16. Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 1997; 337:1485-1490.
17. Gray GE, Urban M, Chersich MF, et al. A randomized trial of two postex-posure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants ofuntreated mothers. AIDS 2005; 19:1289-1297.
18. Otten RA, Smith DK, Adams DR, et al. Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2). J Virol 2000; 74:9771-9775.
19. Taha TE, Kumwenda NI, Gibbons A, et al. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Lancet 2003; 362:1171-1177.
20. Van Rompay KK, Kearney BP, Sexton JJ, et al. Evaluation of oral tenofovir disoproxil fumarate and topical tenofovir GS-7340 to protect infant macaques against repeated oral challenges with virulent simian immunodeficiency virus. J Acquir Immune Defic Syndr 2006; 43:6-14.
21. Roland ME. Postexposure prophylaxis after sexual exposure to HIV. Curr Opin Infect Dis 2007; 20:39-46.
22. Fong C. Post-exposure prophylaxis for HIV infection after sexual assault: When is it indicated? Emerg Med J 2001; 18:242-245.
23. Resnick H, Monnier J, Seals B, et al. Rape-related HIV risk concerns among recent rape victims. J Interpers Violence 2002; 17:746-759.
24. Kilpatrick D, Resnick H, Ruggiero K, et al. Drug-facilitated, Incapacitated, and Forcible Rape: A National Study. Charleston, SC: Medical University of South Carolina, National Crime Victims Research & Treatment Center, 2007.
25. Resnick HS, Holmes MM, Kilpatrick DG, et al. Predictors of post-rape medical care in a national sample of women. Am J Prev Med 2000; 19:214-219.
26. Christofides NJ, Muirhead D, Jewkes RK, et al. Women's experiences of and preferences for services after rape in South Africa: Interview study. BMJ 2006; 332:209-213.
27. Wiebe ER, Comay SE, McGregor M, et al. Offering HIV prophylaxis to people who have been sexually assaulted: 16 months' experience in a sexual assault service. CMAJ 2000; 162:641-645.
28. Babl FE, Cooper ER, Damon B, et al. HIV postexposure prophylaxis for children and adolescents. Am J Emerg Med 2000; 18:282-287.
29. Merchant RC, Becker BM, Mayer KH, et al. Emergency department blood or body fluid exposure evaluations and HIV postexposure prophylaxis usage. Acad Emerg Med 2003; 10:1345-1353.
30. Merchant RC, Keshavarz R, Low C. HIV post-exposure prophylaxis provided at an urban paediatric emergency department to female adolescents after sexual assault. Emerg Med J 2004; 21:449-451.
31. Neu N, Heffernan-Vacca S, Millery M, et al. Postexposure prophylaxis for HIV in children and adolescents after sexual assault: A prospective observational study in an urban medical center. Sex Transm Dis 2007; 34:65-68.
32. Olshen E, Hsu K, Woods ER, et al. Use of human immunodeficiency virus postexposure prophylaxis in adolescent sexual assault victims. Arch Pediatr Adolesc Med 2006; 160:674-680.
33. Loutfy MR, Macdonald S, Myhr T, et al. Prospective cohort study of HIV post-exposure prophylaxis for sexual assault survivors. Antivir Ther 2008; 13:87-95.
34. National Institute of Allergy and Infectious Diseases, National Institutes of Health. Division of Microbiology and Infections Diseases Adult Toxicology Table, November 2007 [draft]. Available at: http://www3.niaid.nih. gov/NR/rdonlyres/401FA10C-8DF2-4162-8B21-25 54129F4294/0/DMIDadulttox.doc. Accessed December 16, 2007.
35. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley, 1989.
36. Mohler-Kuo M, Dowdall GW, Koss MP, et al. Correlates of rape while intoxicated in a national sample of college women. J Stud Alcohol 2004; 65:37-45.
37. Du Mont J, Miller K-L, Myhr TL. The role of "real rape" and "real victim" stereotypes in police reporting practices of sexually assaulted women. Violence Against Women 2003; 9:466 -486.
38. Du Mont J, Parnis D, Forte T. Judicial sentencing in Canadian intimate partner sexual assault cases. Med Law 2006; 25:139-157.
39. Myles JE, Hirozawa A, Katz MH, et al. Postexposure prophylaxis for HIV after sexual assault [research letter]. JAMA 2000;284:1516-1518.